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Two ornithine decarboxylase mRNA species are seen in mouse epidermis in response to the topical applica- 
tion of the phorbol ester tumor promoter, 12-O-tetradecanoyl phorbol-13-acetate (TPA). This induction 
occurs in a time- and dose-dependent fashion and appears to be relatively specific as cc-actin mRNA reveals 
no change with treatment. Both mRNA species are inhibited in a dose-dependent manner by treating mouse 
skin with all-trans-retinoic acid prior to TPA. These results indicate that these two compounds are active 
at the transcriptional level. 
Ornithine decarboxylase mRNA 
1. INTRODUCTION 
The activity of ornithine decarboxylase (EC 
4.1.1.17), the rate-limiting enzyme in polyamine 
biosynthesis, can be induced in a variety of tissues 
and cell lines by numerous stimuli [l]. Among the 
most extensively studied inducers are the phorbol 
ester tumor promoters, in particular 12-0- 
tetradecanoyl phorbol-13-acetate (TPA), which in- 
duces the enzyme in mouse skin [2]. This induction 
in mouse skin has been implicated in tumor pro- 
motion [3]. Furthermore, topically applied vitamin 
A derivatives (retinoids), such as all-trans-retinoic 
acid (RA), inhibit this induction and are known to 
inhibit tumor promotion [4] with a degree of effec- 
tiveness related to their potency of ornithine decar- 
boxylase inhibition [5,6]. At the protein level, it is 
now known that RA inhibits the synthesis of or- 
nithine decarboxylase protein caused by TPA [7]. 
At the mRNA level, a single TPA-inducible 
mRNA species has been reported in mouse skin [8] 
using a radiolabeled cDNA probe, pOD49 [9]. 
Here, utilizing a new method of obtaining RNA 
Phorbol ester Retinoic acid 
from the epidermis, we report the presence of two 
TPA-inducible mRNA species both of which are 
inhibited in a dose-dependent manner by retinoic 
acid. The data described here support the 
hypothesis that the effects of TPA and RA on 
epidermal ornithine decarboxylase are, at least in 
part, mediated transcriptionally. 
2. MATERIALS AND METHODS 
2.1. Tissue source and preparation 
All animals were 7-9-week-old SKH/hr 1 
female hairless mice housed 5 per cage. Animals 
were killed by cervical dislocation, and dorsal skins 
excised and placed in a 55°C water bath containing 
freshly prepared 0.2% diethylpyrocarbonate 
(DEP) for 30 s. The skins were then immediately 
placed in 0-4°C water containing 0.2% DEP. The 
epidermis was scraped from the dermis using a 
scalpel and then quickly frozen in liquid nitrogen. 
2.2. Experimental treatments 
A stock solution of TPA (LC Services, Boston) 
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in acetone was stored at -20°C. RA (Sigma) was 
made up fresh in acetone in a darkened room prior 
to use. 200 ~1 of a given treatment were applied by 
micropipette to the dorsal skin. All animals treated 
with RA were kept in the dark prior to killing. RA 
was always applied 1 h prior to TPA; TPA was ap- 
plied for 4 h unless otherwise indicated. 
2.3. Preparation of RNA for blotting 
Total RNA from mouse epidermis was extracted 
with guanidine thiocyanate (Fluka, Switzerland) 
by the method of Chirgwin et al. [lo]. For Nor- 
thern blots, 15 pg total RNA was denatured with 
glyoxal, electrophoresed on a 1% agarose gel, and 
blotted as described j11,12]. RNA slot blots were 
prepared with 15 yg total RNA by the method of 
Thomas [13]. Both Northern and slot blots were 
prehybridized, hybridized, and washed as de- 
scribed [14]. Autoradiographs were scanned on a 
densitometer for quantification and expressed as 
densitometric units. 
2.4. cDNA probes 
Ornithine decarboxylase mRNA was detected 
with a mouse cDNA clone, pOD48, a gift from Dr 
P. Coffin0 (University of California, San Fran- 
cisco). An @-actin cDNA probe, also from mouse, 
was a gift from Dr N. Davidson (California In- 
B 
stitute of Technology). Both probes were 32P- 
labelled by nick-translation [ 161. 
3. RESULTS AND DISCUSSION 
These studies indicate that the induction of or- 
nithine decarboxylase mRNA by TPA is time- and 
dose-dependent, and that RA inhibits this induc- 
tion in a dose-dependent manner. Northern blot 
analysis of epidermal RNA from mouse skin 
treated with TPA reveals a major mRNA species 
of about 2.1 kb and a minor mRNA species of 
2.4 kb (fig.lA, lane 2; fig.lB, lane 1). The size of 
the major mRNA species is similar to that reported 
in mouse kidney [ 151 and hamster fibroblasts [16]. 
Multiple ornithine decarboxylase mRNA species 
have been documented in other tissues [15-171, 
but in mouse skin, only a single 2.1 kb mRNA 
species has previously been reported [8]. The ex- 
istence of two mRNA species in mouse skin is sup- 
ported by DNA sequence data in mouse kidney in 
which there appear to be two similar, but separate 
ornithine decarboxylase genes [ 181. The applica- 
tion of RA 1 h prior to TPA inhibits the TPA- 
mediated increase of both mRNA species in a dose- 
dependent manner (fig.lB, lanes 2-5). A den- 
sitometric scan of this Northern blot showed that 
both gene products are influenced by the lowest 
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Fig.1. Effects of TPA and RA on ornithine decarboxylase mRNA using Northern (A,B) and slot blot (C) analysis. 
Acetone control (A, lane 1) and 17 nmol TPA alone (A, lane 2; B, lane 1; C, lane 1). Panels B and C, lanes 2-5 in 
each, are 17 nmol TPA together with 1, 5, 10, and 25 nmol RA, respectively. Panel C, lane 6 is 17 nmol TPA together 
with 50 nmol RA. 
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dose (1 nmol) of RA employed (not shown). 
Overall quantitation of both gene products by slot 
blot analysis and a densitometric scan from this 
same experiment reveal that the low dose of 
1 nmol RA inhibits ornithine decarboxylase 
mRNA accumulation by 64%, while 50 nmol in- 
hibits it by 80% (fig.lC). A comparable low dose 
of RA (0.2 nmol) has been reported to inhibit 509’0 
of the TPA-induced enzyme activity in mouse skin 
]51. 
In the absence of TPA (acetone control), no 
detectable levels of ornithine decarboxylase 
mRNA were seen in Northern blots probed with 
cDNA (fig.lA, lane 1). This is probably the result 
of the small amount of this mRNA in our 
unstimulated controls. This sensitivity problem 
was overcome by the use of slot blots in which the 
control can be visualized (fig.2, lane 1); hence, 
TPA’s effect upon ornithine decarboxylase gene 
expression could now be quantified by a den- 
sitometric scan (table 1). As compared to control, 
a 2-fold increase in titratable mRNA was seen at 
1 h, peaking at 4 h (13-fold induction), and declin- 
ing thereafter. This time course correlates well with 
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Fig.2. Slot blot analysis of the appearance of ornithine Fig.3. Treatment with increasing amounts of TPA. 
decarboxylase mRNA in response to TPA. Treatment 15 pg of total RNA was slot blotted and probed with 
with either acetone alone for 4 h (slot 1) or with 17 nmol 32P-labeled ornithine decarboxylase cDNA (A); the same 
TPA for 1, 2, 4, and 6 h (slots 2-5). 50 nmnol RA filter was stripped and reprobed with 32P-labeled actin 
pretreatment for 1 h followed by 17 nmol TPA for 3 h cDNA (B). Slots l-6 are 0.53, 1.06, 2.12, 4.25, 8.5, and 
is also shown (slot 6). 17.0 nmol TPA. 
Table 1 
A densitometric scan of the slot blots shown in fig.2 
Treatment Densitometric Fold increase 
units 
Acetone-acetone 1.2 _ 
Acetone-l h TPA 2.2 1.8 
Acetone-2 h TPA 13.4 11.1 
Acetone-4 h TPA 16.2 13.5 
Acetone-6 h TPA 13.0 10.8 
1 h RA + 3 h TPA 2.3 1.9 
that seen for the induction of enzyme activity in 
mouse skin [5]. 
To ascertain the relative cellular specificity of 
TPA at 4 h, slot blot analysis was performed using 
RNA from mice treated with increasing doses of 
TPA. The expected ose-response pattern was seen 
when the filter was probed for ornithine decarbox- 
ylase mRNA (fig.3A); the same filter reprobed 
with radiolabeled cu-actin cDNA demonstrated no 
change to the highest dose employed (fig.3B). This 
latter result indicates that TPA in this dose range, 
A 
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topically applied for 6 h, does not produce 
widespread gene alterations. All other slot blots 
were similarly reprobed with cu-actin cDNA, and 
no altered level of mRNA was observed even in un- 
treated control epidermis. 
A recent report by Verma and co-workers [B] on 
ornithine decarboxylase mRNA utilized whole 
skin. However, prior studies of enzyme induction 
by TPA and its inhibition by RA have utilized 
epidermis alone, heat-separated from the dermis 
[5]. Hence, in order to perform RNA studies on 
epidermis free of contaminating RNA from the 
dermis, we utilized heat separation of these two 
layers in the presence of the RNase inhibitor DEP. 
This method provides a means to obtain undegrad- 
ed RNA from epidermis and probably accounts for 
our ability to detect an additional mRNA species. 
Several other systems already exist in which 
TPA or RA affect gene transcription. In the F9 
teratocarcinoma cell line, seven independent RA- 
inducible gene sequences have been identified [ 191, 
and in whole animal feeding studies RA can both 
activate and inhibit gene expression [20]. In mouse 
3T3 cells, TPA treatment results in altered 
transcription of several genes as measured in 
nuclear run-off experiments [21]. The strong 
parallels between the mRNA results described 
above and the published literature on the dose- 
response and time course of the induction of the 
enzyme and enzyme protein by TPA, including 
RA’s dose-dependent inhibition of the induced en- 
zyme, lead us to suggest that these well- 
characterized changes in enzyme activity are, at 
least in part, mediated transcriptionally. One 
aspect of the overall significance of these findings 
lies in their providing a better understanding of the 
molecular mechanisms of retinoic acid’s antitumor 
action. As for the phorbol esters, the large increase 
in enzyme activity (230-fold) observed in mouse 
skin in response to TPA [17], which greatly ex- 
ceeds the peak mRNA increase seen in our study 
(13-fold, table l), suggests that other mechanisms 
may still prove to play a role here. Nevertheless, to 
demonstrate unequivocally that TPA and RA 
regulate transcription of the ornithine decarbox- 
ylase gene(s) in skin will require run-off transcrip- 
tion experiments which are difficult to perform in 
the epidermis. Cultured keratinocytes should offer 
more promise here. 
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